{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Imports\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "from matplotlib.colors import to_hex"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "# 2. Constants and configuration\n",
    "INPUT_GRAPH_PATH = \"../data/07-clustered-graphs/alpha0.3_k10_res0.002.graphml\"\n",
    "CLUSTER_INFO_LABEL_TREE = \"../output/cluster-qualifications/ClusterInfoLabelTree.xlsx\"\n",
    "CLUSTER_LABEL_DICT_PATH = \"../data/99-testdata/cluster_label_dict.json\"\n",
    "CLUSTER_TREE_PATH = \"../output/cluster-qualifications/ClusterHierarchy_noComments.json\"\n",
    "OUTPUT_DIR = \"../data/99-testdata/\"\n",
    "THREEJS_OUTPUT_DIR = (\n",
    "    \"/Users/jlq293/Projects/Random Projects/LW-ThreeJS/2d_ssrinetworkviz/src/data/\"\n",
    ")\n",
    "CLUSTER_HIERARCHY_FOR_LEGEND_PATH = (\n",
    "    \"../output/cluster-qualifications/ClusterHierarchy_noComments.json\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [],
   "source": [
    "class ClusterColorAssigner:\n",
    "    \"\"\"\n",
    "    TO DO:\n",
    "    1. clusters not mutually exclusive - need to assign to multiple categories\n",
    "    2. colors too similar - need to assign more distinct colors\n",
    "\n",
    "    A class for assigning colors to clusters based on their characteristics.\n",
    "\n",
    "    This class provides methods to categorize clusters into color palettes,\n",
    "    assign specific colors within those palettes, and create a mapping\n",
    "    between clusters and their assigned colors.\n",
    "\n",
    "    Attributes:\n",
    "        colormaps (dict): A dictionary mapping color names to matplotlib colormaps.\n",
    "        condition_names (dict): A dictionary mapping color names to condition names.\n",
    "\n",
    "    Methods:\n",
    "        assign_color_categories(clust_hierarchy): Assigns color categories to clusters.\n",
    "        print_color_mapping(): Prints the mapping of conditions to color palettes.\n",
    "        assign_colors(df, colormap): Assigns specific colors to clusters within a palette.\n",
    "        create_color_dataframes(clust_hierarchy): Creates separate DataFrames for each color category.\n",
    "        process_cluster_hierarchy(clust_hierarchy): Processes the entire cluster hierarchy.\n",
    "\n",
    "    Usage:\n",
    "        color_assigner = ClusterColorAssigner()\n",
    "        processed_hierarchy, color_dict = color_assigner.process_cluster_hierarchy(cluster_hierarchy_df)\n",
    "    \"\"\"\n",
    "\n",
    "    def __init__(self):\n",
    "        self.colormaps = {\n",
    "            \"blue\": plt.get_cmap(\"Blues\"),\n",
    "            \"red\": plt.get_cmap(\"Reds\"),\n",
    "            \"green\": plt.get_cmap(\"Greens\"),\n",
    "            \"purple\": plt.get_cmap(\"Purples\"),\n",
    "        }\n",
    "        self.condition_names = {\n",
    "            \"blue\": \"pharmacology\",\n",
    "            \"red\": \"indications\",\n",
    "            \"green\": \"safety\",\n",
    "            \"purple\": \"other\",\n",
    "        }\n",
    "\n",
    "    def assign_color_categories(self, clust_hierarchy):\n",
    "        conditions = [\n",
    "            clust_hierarchy[\"pharmacology\"] == 1,\n",
    "            clust_hierarchy[\"indications\"] == 1,\n",
    "            clust_hierarchy[\"safety\"] == 1,\n",
    "            clust_hierarchy[\"other\"] == 1,\n",
    "        ]\n",
    "        choices = [\"blue\", \"red\", \"green\", \"purple\"]\n",
    "        clust_hierarchy[\"color_pal\"] = np.select(conditions, choices, default=\"\")\n",
    "        return clust_hierarchy\n",
    "\n",
    "    def print_color_mapping(self):\n",
    "        print(\"Mapping of conditions to color palettes:\")\n",
    "        for color, condition in self.condition_names.items():\n",
    "            print(f\"{condition.capitalize()}: {color}\")\n",
    "\n",
    "    @staticmethod\n",
    "    def assign_colors(df, colormap):\n",
    "        num_colors = df.shape[0]\n",
    "        colors = [to_hex(colormap(x)) for x in np.linspace(0.1, 0.9, num_colors)]\n",
    "        df[\"color\"] = colors\n",
    "        return df\n",
    "\n",
    "    def create_color_dataframes(self, clust_hierarchy):\n",
    "        color_dfs = {}\n",
    "        for color_name, colormap in self.colormaps.items():\n",
    "            df_color = clust_hierarchy[\n",
    "                clust_hierarchy[\"color_pal\"] == color_name\n",
    "            ].copy()\n",
    "            if not df_color.empty:\n",
    "                color_dfs[color_name] = self.assign_colors(df_color, colormap)\n",
    "        return color_dfs\n",
    "\n",
    "    def process_cluster_hierarchy(self, clust_hierarchy):\n",
    "        # Assign color categories\n",
    "        clust_hierarchy = self.assign_color_categories(clust_hierarchy)\n",
    "        self.print_color_mapping()\n",
    "\n",
    "        # Create color dataframes\n",
    "        color_dfs = self.create_color_dataframes(clust_hierarchy)\n",
    "\n",
    "        # Concatenate the color dataframes\n",
    "        colored_hierarchy = pd.concat(color_dfs.values(), ignore_index=True)\n",
    "\n",
    "        # Find and reinsert any missing clusters (without a color)\n",
    "        missing_clusters = clust_hierarchy.loc[\n",
    "            ~clust_hierarchy[\"cluster\"].isin(colored_hierarchy[\"cluster\"])\n",
    "        ]\n",
    "        if not missing_clusters.empty:\n",
    "            missing_clusters[\"color\"] = \"gray\"  # Assign a default color (e.g., gray)\n",
    "            colored_hierarchy = pd.concat(\n",
    "                [colored_hierarchy, missing_clusters], ignore_index=True\n",
    "            )\n",
    "\n",
    "        # Create cluster-color dictionary\n",
    "        cluster_color_dict = dict(\n",
    "            zip(colored_hierarchy[\"cluster\"], colored_hierarchy[\"color\"])\n",
    "        )\n",
    "\n",
    "        return colored_hierarchy, cluster_color_dict\n",
    "\n",
    "    def save_dict_to_json(self, dict, path):\n",
    "        with open(path, \"w\") as f:\n",
    "            json.dump(dict, f)\n",
    "        print(f\"Cluster color dictionary saved to {path}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "clust_hierarchy = pd.read_excel(CLUSTER_INFO_LABEL_TREE)\n",
    "clust_hierarchy  # Q[\"cluster\"].head(10)\n",
    "\n",
    "cluster_label_dict = dict(\n",
    "    zip(clust_hierarchy[\"cluster\"], clust_hierarchy[\"clusterlabel\"])\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{0: 'Serotonin Receptor Studies',\n",
       " 1: 'Aquatic Ecotoxicology',\n",
       " 2: 'Risks of Prenatal Exposure',\n",
       " 3: 'Quantification of SSRIs in Biological Samples',\n",
       " 4: 'SSRIs for Obsessive-Compulsive Disorder (OCD)',\n",
       " 5: 'SSRIs and the Cytochrome P450 System',\n",
       " 6: 'SSRI Neuroscience',\n",
       " 7: 'Pediatric Depression',\n",
       " 8: 'The Chronic Unpredictable Mild Stress Model of Depression',\n",
       " 9: 'Fluvoxamine for Depression',\n",
       " 10: 'Paroxetine Bindeing',\n",
       " 11: 'SSRIs Effect on Neural Processing of Emotional Cues',\n",
       " 12: 'Risks of Prenatal Exposure (Rodents)',\n",
       " 13: 'SSRIs for PTSD',\n",
       " 14: 'SSRIs in Forced Swimming Test',\n",
       " 15: 'Serotonin Syndrome',\n",
       " 16: 'Sexual Dysfunction',\n",
       " 17: 'Sequenced Depression Treatment',\n",
       " 18: 'Post-Stroke SSRI Use',\n",
       " 19: 'SSRIs Effect on Fear',\n",
       " 20: 'Bleeding Risk',\n",
       " 21: 'Serotonin Transporter Gene and Antidepressant Response',\n",
       " 22: 'SSRIs and Inflammation',\n",
       " 23: 'Escitalopram for Depression',\n",
       " 24: 'SSRIs for Pain',\n",
       " 25: 'SSRI Utilization Patterns',\n",
       " 26: 'SSRIs in Dementias',\n",
       " 27: 'SSRIs for Weight Management',\n",
       " 28: 'Suicice Risk',\n",
       " 29: 'SSRIs and Cardiovascular Pathology',\n",
       " 30: 'Serotonin Binding and Receptor Studies',\n",
       " 31: 'SSRIs for Panic Disorder',\n",
       " 32: 'Paroxetine',\n",
       " 33: 'Cost-Effectiveness',\n",
       " 34: 'SSRIs for Dermatological Diseases',\n",
       " 35: 'Herbal and Natural Compounds for Depression',\n",
       " 36: 'SSRIs for Generalized Anxiety Disorder (GAD)',\n",
       " 37: 'Fracture Risk',\n",
       " 38: 'SSRIs for Bipolar Depression',\n",
       " 39: 'Fluvoxamine for Covid 19',\n",
       " 40: 'QTC Prolongation',\n",
       " 41: 'Fluoxetine',\n",
       " 42: 'Extrapyramidal Reactions Risk',\n",
       " 43: 'Premature Ejaculation',\n",
       " 44: 'SSRIs for Depression in Parkinsons Patients',\n",
       " 45: 'Oncopreventive and Oncolytic Properties of SSRIs',\n",
       " 46: 'SSRIs Effect on Sleep in Depressed Patients',\n",
       " 47: 'SSRIs for Depression in Diabetes Patients',\n",
       " 48: 'SSRIs for Irritable Bowel Syndrome',\n",
       " 49: 'SSRIs for Premenstrual Dysphoric Disorder (PMDD)',\n",
       " 50: 'SSRIs for Depression with Cognitive Impairment',\n",
       " 51: 'SSRIs for Eating Disorders',\n",
       " 52: 'SSRIs for Alcohol Dependence',\n",
       " 53: 'Hot Flushes (Menopause)',\n",
       " 54: '(Sertraline) Drug Delivery',\n",
       " 55: 'SSRIs for Depression in in Epileptic Patients',\n",
       " 56: 'SSRIs for Autism Spectrum Disorders',\n",
       " 57: 'SSRIs for Substance Abuse (Cocaine)',\n",
       " 58: 'Hepatotoxic Risk',\n",
       " 59: 'SSRIs (Fluvoxamine) for Schizophrenia',\n",
       " 60: 'SSRI Synthesis',\n",
       " 61: 'Sertraline for Depression',\n",
       " 62: 'SSRIs for Social Anxiety Disorder',\n",
       " 63: 'Drug Drug Interactions',\n",
       " 64: 'SSRIs Effects on Ion Channels',\n",
       " 65: 'Methylenedioxymethamphetamine (MDMA) Effects on Serotonin',\n",
       " 66: 'Genotype Mediated Response to SSRIs',\n",
       " 67: 'Pharmacological Perspectives on Antidepressants',\n",
       " 68: 'Hyponatremia Risk',\n",
       " 69: 'SSRIs for Body Dysmorphic Disorder (BDD)',\n",
       " 70: 'SSRIs Effects on Neuroendocrine System',\n",
       " 71: 'SSRIs for Pediatric Anxiety',\n",
       " 72: 'SSRI Safety Reviews',\n",
       " 73: 'SSRIs Effects on Antimicrobials and Gut Microbiome',\n",
       " 74: 'Depression Treatment Review',\n",
       " 75: 'Agomelatin for Depression',\n",
       " 76: 'Geriatric Depression',\n",
       " 77: 'Citalopram for Depression',\n",
       " 78: 'SSRIs for Personality Disorders and Related Traits',\n",
       " 79: 'Forensic Drug Concentration',\n",
       " 80: 'Pulmonary Hypertension',\n",
       " 81: 'Astrocyte Receptors',\n",
       " 82: 'Withdrawal Symptoms',\n",
       " 83: 'Wastewater Management',\n",
       " 84: 'SSRI Use',\n",
       " 85: 'Depression in Hepatitis Patients',\n",
       " 86: 'SSRIs and Augmentation for Treatment Resistant Depression',\n",
       " 87: 'SSRIs for Depression after Traumatic Brain Injury',\n",
       " 88: 'Repeated SSRIs Exposures Effects on Dopamine Receptors',\n",
       " 89: 'Hyperprolactinemia-related Symptoms',\n",
       " 90: 'Neurochemical and Electrophysiological Correlates of SSRIs',\n",
       " 91: 'SSRIs for Fibromyalgia',\n",
       " 92: 'Sex differences in SSRI Effects in Depression',\n",
       " 93: 'SRRIs and Ocular Safety',\n",
       " 94: 'SSRIs for OCD-like behaviors',\n",
       " 95: 'Transcranial Direct Current Stimulation (tDCS) for Depression',\n",
       " 96: 'SSRIs for Depression in Cancer',\n",
       " 97: 'SSRI-Induced Mania',\n",
       " 98: 'Gatways to Clinical Trials',\n",
       " 99: 'Sertraline',\n",
       " 100: 'Canine Behavioral Disorders',\n",
       " 101: 'Risk for Orofacial Pain Disorders',\n",
       " 102: 'SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients',\n",
       " 103: 'SSRIs for Enuresis',\n",
       " 104: 'SSRIs for Migraine',\n",
       " 105: 'SSRIs for Postpartum Depression',\n",
       " 106: \"St. John's Wort for Depression\",\n",
       " 107: 'SSRIs for Depression in Kidney Disease Patients',\n",
       " 108: 'Behavioral Addictions',\n",
       " 109: 'SSRIs Effect on Response Inhibition',\n",
       " 110: 'SSRIs for Dysthymia',\n",
       " 111: 'Generic SSRIs',\n",
       " 112: 'SSRIs in Model Organisms ( C. Elegans and Drosophilia)',\n",
       " 113: 'Vilazodone for Depression',\n",
       " 114: 'SSRIs for Trichotillomania',\n",
       " 115: 'Selective serotonin reuptake inhibitors',\n",
       " 116: 'SSRIs for Depression in and Treatment of Multiple Sclerosis',\n",
       " 117: 'SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients',\n",
       " 118: 'Folate for Depression',\n",
       " 119: 'Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor for Cardiovascular Diseases',\n",
       " 120: 'Tryptophan Depletion in Depression',\n",
       " 121: 'Serotonin and Dopamine Release and Uptake Dynamics',\n",
       " 122: 'SSRIs for Congenital Myasthenic Syndrome (SCCMS)',\n",
       " 123: 'Olfactory Bulbectomized (OB) Rat Model for Depression',\n",
       " 124: 'SSRIs for Depression in HIV-positive Patients',\n",
       " 125: 'SSRIs for Smoking Cessation',\n",
       " 126: 'Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression',\n",
       " 127: 'SSRIs for Tinnitus ',\n",
       " 128: 'SSRIs for Syncope',\n",
       " 129: 'Novel Compounds Synthesis and Antidepressant Potential',\n",
       " 130: 'Risk of Hallucinations',\n",
       " 131: 'Exercise for Depression',\n",
       " 132: 'SSRIs for Narcolepsy',\n",
       " 133: 'SSRIs and Galanin in Depression',\n",
       " 134: \"SSRIs for Tourette's Syndrome\",\n",
       " 135: 'Adulterants in Weight Loss Supplements',\n",
       " 136: 'Risk of Microscopic Colitis',\n",
       " 137: 'SSRIs for Pediatric OCD',\n",
       " 138: 'SSRIs Cellular Distribution',\n",
       " 139: 'Psychotic Depression (STOP-PD Study)',\n",
       " 140: 'Treatment of Paroxetine Induced Sexual Dysfunction',\n",
       " 141: 'Childhood Abuse and Depression Treatment Response',\n",
       " 142: 'Risk of Priapism',\n",
       " 143: 'Psilocybin for Depression',\n",
       " 144: 'SSRIs for Depersonalization Disorder',\n",
       " 145: 'Risk of Reversible Cerebral Vasoconstriction Syndrome (RCVS)',\n",
       " 146: 'Gateways to Clinical Trials',\n",
       " 147: 'Depression in Infertile Women',\n",
       " 148: 'SSRIs for Olfactory reference syndrome (ORS)'}"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cluster_label_dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mapping of conditions to color palettes:\n",
      "Pharmacology: blue\n",
      "Indications: red\n",
      "Safety: green\n",
      "Other: purple\n",
      "Cluster color dictionary saved to ../data/99-testdata/cluster_color_dict.json\n",
      "Cluster color dictionary saved to ../data/99-testdata/cluster_label_dict.json\n",
      "\n",
      "Cluster color dictionary (first 5 items):\n",
      "{0: '#e3eef9', 2: '#dfebf7', 3: '#dbe9f6', 5: '#d6e6f4', 6: '#d3e3f3'}\n",
      "\n",
      "Cluster label dictionary (first 5 items):\n",
      "{0: 'Serotonin Receptor Studies', 2: 'Risks of Prenatal Exposure', 3: 'Quantification of SSRIs in Biological Samples', 5: 'SSRIs and the Cytochrome P450 System', 6: 'SSRI Neuroscience'}\n"
     ]
    }
   ],
   "source": [
    "clust_hierarchy = pd.read_excel(CLUSTER_INFO_LABEL_TREE)\n",
    "clust_hierarchy.sort_values(by=\"cluster\", inplace=True)\n",
    "\n",
    "color_assigner = ClusterColorAssigner()\n",
    "clust_hierarchy, cluster_color_dict = color_assigner.process_cluster_hierarchy(\n",
    "    clust_hierarchy\n",
    ")\n",
    "\n",
    "color_assigner.save_dict_to_json(\n",
    "    cluster_color_dict, OUTPUT_DIR + \"cluster_color_dict.json\"\n",
    ")\n",
    "\n",
    "cluster_label_dict = dict(\n",
    "    zip(clust_hierarchy[\"cluster\"], clust_hierarchy[\"clusterlabel\"])\n",
    ")\n",
    "\n",
    "color_assigner.save_dict_to_json(cluster_label_dict, CLUSTER_LABEL_DICT_PATH)\n",
    "\n",
    "print(\"\\nCluster color dictionary (first 5 items):\")\n",
    "print(dict(list(cluster_color_dict.items())[:5]))\n",
    "print(\"\\nCluster label dictionary (first 5 items):\")\n",
    "print(dict(list(cluster_label_dict.items())[:5]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'SSRIs for Panic Disorder'"
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cluster_label_dict[31]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[0,\n",
       " 1,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 5,\n",
       " 6,\n",
       " 7,\n",
       " 8,\n",
       " 9,\n",
       " 10,\n",
       " 11,\n",
       " 12,\n",
       " 13,\n",
       " 14,\n",
       " 15,\n",
       " 16,\n",
       " 17,\n",
       " 18,\n",
       " 19,\n",
       " 20,\n",
       " 21,\n",
       " 22,\n",
       " 23,\n",
       " 24,\n",
       " 25,\n",
       " 26,\n",
       " 27,\n",
       " 28,\n",
       " 29,\n",
       " 30,\n",
       " 31,\n",
       " 32,\n",
       " 33,\n",
       " 34,\n",
       " 35,\n",
       " 36,\n",
       " 37,\n",
       " 38,\n",
       " 39,\n",
       " 40,\n",
       " 41,\n",
       " 42,\n",
       " 43,\n",
       " 44,\n",
       " 45,\n",
       " 46,\n",
       " 47,\n",
       " 48,\n",
       " 49,\n",
       " 50,\n",
       " 51,\n",
       " 52,\n",
       " 53,\n",
       " 54,\n",
       " 55,\n",
       " 56,\n",
       " 57,\n",
       " 58,\n",
       " 59,\n",
       " 60,\n",
       " 61,\n",
       " 62,\n",
       " 63,\n",
       " 64,\n",
       " 65,\n",
       " 66,\n",
       " 67,\n",
       " 68,\n",
       " 69,\n",
       " 70,\n",
       " 71,\n",
       " 72,\n",
       " 73,\n",
       " 74,\n",
       " 75,\n",
       " 76,\n",
       " 77,\n",
       " 78,\n",
       " 79,\n",
       " 80,\n",
       " 81,\n",
       " 82,\n",
       " 83,\n",
       " 84,\n",
       " 85,\n",
       " 86,\n",
       " 87,\n",
       " 88,\n",
       " 89,\n",
       " 90,\n",
       " 91,\n",
       " 92,\n",
       " 93,\n",
       " 94,\n",
       " 95,\n",
       " 96,\n",
       " 97,\n",
       " 98,\n",
       " 99,\n",
       " 100,\n",
       " 101,\n",
       " 102,\n",
       " 103,\n",
       " 104,\n",
       " 105,\n",
       " 106,\n",
       " 107,\n",
       " 108,\n",
       " 109,\n",
       " 110,\n",
       " 111,\n",
       " 112,\n",
       " 113,\n",
       " 114,\n",
       " 115,\n",
       " 116,\n",
       " 117,\n",
       " 118,\n",
       " 119,\n",
       " 120,\n",
       " 121,\n",
       " 122,\n",
       " 123,\n",
       " 124,\n",
       " 125,\n",
       " 126,\n",
       " 127,\n",
       " 128,\n",
       " 129,\n",
       " 130,\n",
       " 131,\n",
       " 132,\n",
       " 133,\n",
       " 134,\n",
       " 135,\n",
       " 136,\n",
       " 137,\n",
       " 138,\n",
       " 139,\n",
       " 140,\n",
       " 141,\n",
       " 142,\n",
       " 143,\n",
       " 144,\n",
       " 145,\n",
       " 146,\n",
       " 147,\n",
       " 148]"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ks = list([int(k) for k in cluster_label_dict.keys()])\n",
    "ks.sort()\n",
    "ks"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# legend json creation\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "  \"Pharmacology\": {\n",
      "    \"Pharmacodynamics\": {\n",
      "      \"Mechanism of action\": [\n",
      "        {\n",
      "          \"0\": \"Serotonin Receptor Studies\"\n",
      "        },\n",
      "        {\n",
      "          \"10\": \"Paroxetine Bindeing\"\n",
      "        },\n",
      "        {\n",
      "          \"19\": \"SSRIs Effect on Fear\"\n",
      "        },\n",
      "        {\n",
      "          \"11\": \"SSRIs Effect on Neural Processing of Emotional Cues\"\n",
      "        },\n",
      "        {\n",
      "          \"30\": \"Serotonin Binding and Receptor Studies\"\n",
      "        },\n",
      "        {\n",
      "          \"81\": \"Astrocyte Receptors\"\n",
      "        },\n",
      "        {\n",
      "          \"88\": \"Repeated SSRIs Exposures Effects on Dopamine Receptors\"\n",
      "        },\n",
      "        {\n",
      "          \"90\": \"Neurochemical and Electrophysiological Correlates of SSRIs\"\n",
      "        },\n",
      "        {\n",
      "          \"94\": \"SSRIs for OCD-like behaviors\"\n",
      "        },\n",
      "        {\n",
      "          \"112\": \"SSRIs in Model Organisms ( C. Elegans and Drosophilia)\"\n",
      "        },\n",
      "        {\n",
      "          \"120\": \"Tryptophan Depletion in Depression\"\n",
      "        }\n",
      "      ],\n",
      "      \"Animal Models of Disorders\": [\n",
      "        {\n",
      "          \"8\": \"The Chronic Unpredictable Mild Stress Model of Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"14\": \"SSRIs in Forced Swimming Test\"\n",
      "        },\n",
      "        {\n",
      "          \"109\": \"SSRIs Effect on Response Inhibition\"\n",
      "        },\n",
      "        {\n",
      "          \"123\": \"Olfactory Bulbectomized (OB) Rat Model for Depression\"\n",
      "        }\n",
      "      ],\n",
      "      \"OtherPharmacodynamics\": [\n",
      "        {\n",
      "          \"6\": \"SSRI Neuroscience\"\n",
      "        },\n",
      "        {\n",
      "          \"64\": \"SSRIs Effects on Ion Channels\"\n",
      "        },\n",
      "        {\n",
      "          \"65\": \"Methylenedioxymethamphetamine (MDMA) Effects on Serotonin\"\n",
      "        },\n",
      "        {\n",
      "          \"80\": \"Pulmonary Hypertension\"\n",
      "        },\n",
      "        {\n",
      "          \"92\": \"Sex differences in SSRI Effects in Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"119\": \"Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor for Cardiovascular Diseases\"\n",
      "        },\n",
      "        {\n",
      "          \"121\": \"Serotonin and Dopamine Release and Uptake Dynamics\"\n",
      "        },\n",
      "        {\n",
      "          \"133\": \"SSRIs and Galanin in Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"138\": \"SSRIs Cellular Distribution\"\n",
      "        },\n",
      "        {\n",
      "          \"140\": \"Treatment of Paroxetine Induced Sexual Dysfunction\"\n",
      "        }\n",
      "      ]\n",
      "    },\n",
      "    \"Pharmacokinetics\": [\n",
      "      {\n",
      "        \"5\": \"SSRIs and the Cytochrome P450 System\"\n",
      "      },\n",
      "      {\n",
      "        \"54\": \"(Sertraline) Drug Delivery\"\n",
      "      }\n",
      "    ],\n",
      "    \"Pharmacogenetics\": [\n",
      "      {\n",
      "        \"21\": \"Serotonin Transporter Gene and Antidepressant Response\"\n",
      "      },\n",
      "      {\n",
      "        \"66\": \"Genotype Mediated Response to SSRIs\"\n",
      "      }\n",
      "    ],\n",
      "    \"Analytical Methods\": [\n",
      "      {\n",
      "        \"3\": \"Quantification of SSRIs in Biological Samples\"\n",
      "      },\n",
      "      {\n",
      "        \"129\": \"Novel Compounds Synthesis and Antidepressant Potential\"\n",
      "      }\n",
      "    ],\n",
      "    \"Biomarker Search\": [\n",
      "      {\n",
      "        \"10\": \"Paroxetine Bindeing\"\n",
      "      },\n",
      "      {\n",
      "        \"22\": \"SSRIs and Inflammation\"\n",
      "      },\n",
      "      {\n",
      "        \"102\": \"SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients\"\n",
      "      },\n",
      "      {\n",
      "        \"126\": \"Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression\"\n",
      "      }\n",
      "    ],\n",
      "    \"OtherPharmacology\": [\n",
      "      {\n",
      "        \"2\": \"Risks of Prenatal Exposure\"\n",
      "      },\n",
      "      {\n",
      "        \"60\": \"SSRI Synthesis\"\n",
      "      },\n",
      "      {\n",
      "        \"70\": \"SSRIs Effects on Neuroendocrine System\"\n",
      "      },\n",
      "      {\n",
      "        \"67\": \"Pharmacological Perspectives on Antidepressants\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  \"Indications\": {\n",
      "    \"Disorders\": {\n",
      "      \"Depression\": [\n",
      "        {\n",
      "          \"7\": \"Pediatric Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"8\": \"The Chronic Unpredictable Mild Stress Model of Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"14\": \"SSRIs in Forced Swimming Test\"\n",
      "        },\n",
      "        {\n",
      "          \"17\": \"Sequenced Depression Treatment\"\n",
      "        },\n",
      "        {\n",
      "          \"18\": \"Post-Stroke SSRI Use\"\n",
      "        },\n",
      "        {\n",
      "          \"22\": \"SSRIs and Inflammation\"\n",
      "        },\n",
      "        {\n",
      "          \"23\": \"Escitalopram for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"29\": \"SSRIs and Cardiovascular Pathology\"\n",
      "        },\n",
      "        {\n",
      "          \"38\": \"SSRIs for Bipolar Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"44\": \"SSRIs for Depression in Parkinsons Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"46\": \"SSRIs Effect on Sleep in Depressed Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"47\": \"SSRIs for Depression in Diabetes Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"49\": \"SSRIs for Premenstrual Dysphoric Disorder (PMDD)\"\n",
      "        },\n",
      "        {\n",
      "          \"50\": \"SSRIs for Depression with Cognitive Impairment\"\n",
      "        },\n",
      "        {\n",
      "          \"55\": \"SSRIs for Depression in in Epileptic Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"61\": \"Sertraline for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"74\": \"Depression Treatment Review\"\n",
      "        },\n",
      "        {\n",
      "          \"75\": \"Agomelatin for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"76\": \"Geriatric Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"77\": \"Citalopram for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"85\": \"Depression in Hepatitis Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"86\": \"SSRIs and Augmentation for Treatment Resistant Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"87\": \"SSRIs for Depression after Traumatic Brain Injury\"\n",
      "        },\n",
      "        {\n",
      "          \"92\": \"Sex differences in SSRI Effects in Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"95\": \"Transcranial Direct Current Stimulation (tDCS) for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"96\": \"SSRIs for Depression in Cancer\"\n",
      "        },\n",
      "        {\n",
      "          \"102\": \"SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"105\": \"SSRIs for Postpartum Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"107\": \"SSRIs for Depression in Kidney Disease Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"113\": \"Vilazodone for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"116\": \"SSRIs for Depression in and Treatment of Multiple Sclerosis\"\n",
      "        },\n",
      "        {\n",
      "          \"117\": \"SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"118\": \"Folate for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"120\": \"Tryptophan Depletion in Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"124\": \"SSRIs for Depression in HIV-positive Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"126\": \"Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"129\": \"Novel Compounds Synthesis and Antidepressant Potential\"\n",
      "        },\n",
      "        {\n",
      "          \"131\": \"Exercise for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"133\": \"SSRIs and Galanin in Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"139\": \"Psychotic Depression (STOP-PD Study)\"\n",
      "        },\n",
      "        {\n",
      "          \"141\": \"Childhood Abuse and Depression Treatment Response\"\n",
      "        },\n",
      "        {\n",
      "          \"143\": \"Psilocybin for Depression\"\n",
      "        }\n",
      "      ],\n",
      "      \"Anxiety\": [\n",
      "        {\n",
      "          \"19\": \"SSRIs Effect on Fear\"\n",
      "        },\n",
      "        {\n",
      "          \"31\": \"SSRIs for Panic Disorder\"\n",
      "        },\n",
      "        {\n",
      "          \"36\": \"SSRIs for Generalized Anxiety Disorder (GAD)\"\n",
      "        },\n",
      "        {\n",
      "          \"62\": \"SSRIs for Social Anxiety Disorder\"\n",
      "        },\n",
      "        {\n",
      "          \"71\": \"SSRIs for Pediatric Anxiety\"\n",
      "        }\n",
      "      ],\n",
      "      \"OCD\": [\n",
      "        {\n",
      "          \"4\": \"SSRIs for Obsessive-Compulsive Disorder (OCD)\"\n",
      "        },\n",
      "        {\n",
      "          \"94\": \"SSRIs for OCD-like behaviors\"\n",
      "        },\n",
      "        {\n",
      "          \"137\": \"SSRIs for Pediatric OCD\"\n",
      "        }\n",
      "      ],\n",
      "      \"Weight and Eating Disorders\": [\n",
      "        {\n",
      "          \"27\": \"SSRIs for Weight Management\"\n",
      "        },\n",
      "        {\n",
      "          \"51\": \"SSRIs for Eating Disorders\"\n",
      "        }\n",
      "      ],\n",
      "      \"Substance Abuse/Addictions\": [\n",
      "        {\n",
      "          \"52\": \"SSRIs for Alcohol Dependence\"\n",
      "        },\n",
      "        {\n",
      "          \"57\": \"SSRIs for Substance Abuse (Cocaine)\"\n",
      "        },\n",
      "        {\n",
      "          \"108\": \"Behavioral Addictions\"\n",
      "        },\n",
      "        {\n",
      "          \"125\": \"SSRIs for Smoking Cessation\"\n",
      "        }\n",
      "      ],\n",
      "      \"OtherDisorders\": [\n",
      "        {\n",
      "          \"13\": \"SSRIs for PTSD\"\n",
      "        },\n",
      "        {\n",
      "          \"24\": \"SSRIs for Pain\"\n",
      "        },\n",
      "        {\n",
      "          \"26\": \"SSRIs in Dementias\"\n",
      "        },\n",
      "        {\n",
      "          \"34\": \"SSRIs for Dermatological Diseases\"\n",
      "        },\n",
      "        {\n",
      "          \"36\": \"SSRIs for Generalized Anxiety Disorder (GAD)\"\n",
      "        },\n",
      "        {\n",
      "          \"43\": \"Premature Ejaculation\"\n",
      "        },\n",
      "        {\n",
      "          \"48\": \"SSRIs for Irritable Bowel Syndrome\"\n",
      "        },\n",
      "        {\n",
      "          \"53\": \"Hot Flushes (Menopause)\"\n",
      "        },\n",
      "        {\n",
      "          \"56\": \"SSRIs for Autism Spectrum Disorders\"\n",
      "        },\n",
      "        {\n",
      "          \"59\": \"SSRIs (Fluvoxamine) for Schizophrenia\"\n",
      "        },\n",
      "        {\n",
      "          \"69\": \"SSRIs for Body Dysmorphic Disorder (BDD)\"\n",
      "        },\n",
      "        {\n",
      "          \"73\": \"SSRIs Effects on Antimicrobials and Gut Microbiome\"\n",
      "        },\n",
      "        {\n",
      "          \"78\": \"SSRIs for Personality Disorders and Related Traits\"\n",
      "        },\n",
      "        {\n",
      "          \"91\": \"SSRIs for Fibromyalgia\"\n",
      "        },\n",
      "        {\n",
      "          \"103\": \"SSRIs for Enuresis\"\n",
      "        },\n",
      "        {\n",
      "          \"104\": \"SSRIs for Migraine\"\n",
      "        },\n",
      "        {\n",
      "          \"110\": \"SSRIs for Dysthymia\"\n",
      "        },\n",
      "        {\n",
      "          \"114\": \"SSRIs for Trichotillomania\"\n",
      "        },\n",
      "        {\n",
      "          \"119\": \"Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor for Cardiovascular Diseases\"\n",
      "        },\n",
      "        {\n",
      "          \"122\": \"SSRIs for Congenital Myasthenic Syndrome (SCCMS)\"\n",
      "        },\n",
      "        {\n",
      "          \"123\": \"Olfactory Bulbectomized (OB) Rat Model for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"127\": \"SSRIs for Tinnitus \"\n",
      "        },\n",
      "        {\n",
      "          \"128\": \"SSRIs for Syncope\"\n",
      "        },\n",
      "        {\n",
      "          \"132\": \"SSRIs for Narcolepsy\"\n",
      "        },\n",
      "        {\n",
      "          \"134\": \"SSRIs for Tourette's Syndrome\"\n",
      "        },\n",
      "        {\n",
      "          \"144\": \"SSRIs for Depersonalization Disorder\"\n",
      "        },\n",
      "        {\n",
      "          \"147\": \"Depression in Infertile Women\"\n",
      "        },\n",
      "        {\n",
      "          \"148\": \"SSRIs for Olfactory reference syndrome (ORS)\"\n",
      "        }\n",
      "      ]\n",
      "    },\n",
      "    \"OtherIndications\": []\n",
      "  },\n",
      "  \"Safety\": {\n",
      "    \"Special Populations\": {\n",
      "      \"Pediatrics\": [\n",
      "        {\n",
      "          \"7\": \"Pediatric Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"71\": \"SSRIs for Pediatric Anxiety\"\n",
      "        },\n",
      "        {\n",
      "          \"141\": \"Childhood Abuse and Depression Treatment Response\"\n",
      "        },\n",
      "        {\n",
      "          \"137\": \"SSRIs for Pediatric OCD\"\n",
      "        }\n",
      "      ],\n",
      "      \"Geriatrics\": [\n",
      "        {\n",
      "          \"26\": \"SSRIs in Dementias\"\n",
      "        },\n",
      "        {\n",
      "          \"37\": \"Fracture Risk\"\n",
      "        },\n",
      "        {\n",
      "          \"50\": \"SSRIs for Depression with Cognitive Impairment\"\n",
      "        },\n",
      "        {\n",
      "          \"44\": \"SSRIs for Depression in Parkinsons Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"63\": \"Drug Drug Interactions\"\n",
      "        },\n",
      "        {\n",
      "          \"68\": \"Hyponatremia Risk\"\n",
      "        },\n",
      "        {\n",
      "          \"76\": \"Geriatric Depression\"\n",
      "        }\n",
      "      ],\n",
      "      \"OtherPopulations\": [\n",
      "        {\n",
      "          \"18\": \"Post-Stroke SSRI Use\"\n",
      "        },\n",
      "        {\n",
      "          \"29\": \"SSRIs and Cardiovascular Pathology\"\n",
      "        },\n",
      "        {\n",
      "          \"47\": \"SSRIs for Depression in Diabetes Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"55\": \"SSRIs for Depression in in Epileptic Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"85\": \"Depression in Hepatitis Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"87\": \"SSRIs for Depression after Traumatic Brain Injury\"\n",
      "        },\n",
      "        {\n",
      "          \"96\": \"SSRIs for Depression in Cancer\"\n",
      "        },\n",
      "        {\n",
      "          \"107\": \"SSRIs for Depression in Kidney Disease Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"116\": \"SSRIs for Depression in and Treatment of Multiple Sclerosis\"\n",
      "        },\n",
      "        {\n",
      "          \"117\": \"SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients\"\n",
      "        },\n",
      "        {\n",
      "          \"124\": \"SSRIs for Depression in HIV-positive Patients\"\n",
      "        }\n",
      "      ]\n",
      "    },\n",
      "    \"Prenatal Exposure\": [\n",
      "      {\n",
      "        \"2\": \"Risks of Prenatal Exposure\"\n",
      "      },\n",
      "      {\n",
      "        \"12\": \"Risks of Prenatal Exposure (Rodents)\"\n",
      "      }\n",
      "    ],\n",
      "    \"Pregnancy\": [],\n",
      "    \"Suicide\": [\n",
      "      {\n",
      "        \"7\": \"Pediatric Depression\"\n",
      "      },\n",
      "      {\n",
      "        \"28\": \"Suicice Risk\"\n",
      "      }\n",
      "    ],\n",
      "    \"Sexual Dysfunction\": [\n",
      "      {\n",
      "        \"16\": \"Sexual Dysfunction\"\n",
      "      },\n",
      "      {\n",
      "        \"140\": \"Treatment of Paroxetine Induced Sexual Dysfunction\"\n",
      "      }\n",
      "    ],\n",
      "    \"Toxicity\": [\n",
      "      {\n",
      "        \"15\": \"Serotonin Syndrome\"\n",
      "      },\n",
      "      {\n",
      "        \"58\": \"Hepatotoxic Risk\"\n",
      "      },\n",
      "      {\n",
      "        \"79\": \"Forensic Drug Concentration\"\n",
      "      }\n",
      "    ],\n",
      "    \"Cardiovascular\": [\n",
      "      {\n",
      "        \"29\": \"SSRIs and Cardiovascular Pathology\"\n",
      "      },\n",
      "      {\n",
      "        \"40\": \"QTC Prolongation\"\n",
      "      },\n",
      "      {\n",
      "        \"80\": \"Pulmonary Hypertension\"\n",
      "      }\n",
      "    ],\n",
      "    \"OtherSafety\": [\n",
      "      {\n",
      "        \"20\": \"Bleeding Risk\"\n",
      "      },\n",
      "      {\n",
      "        \"37\": \"Fracture Risk\"\n",
      "      },\n",
      "      {\n",
      "        \"42\": \"Extrapyramidal Reactions Risk\"\n",
      "      },\n",
      "      {\n",
      "        \"45\": \"Oncopreventive and Oncolytic Properties of SSRIs\"\n",
      "      },\n",
      "      {\n",
      "        \"63\": \"Drug Drug Interactions\"\n",
      "      },\n",
      "      {\n",
      "        \"68\": \"Hyponatremia Risk\"\n",
      "      },\n",
      "      {\n",
      "        \"72\": \"SSRI Safety Reviews\"\n",
      "      },\n",
      "      {\n",
      "        \"80\": \"Pulmonary Hypertension\"\n",
      "      },\n",
      "      {\n",
      "        \"82\": \"Withdrawal Symptoms\"\n",
      "      },\n",
      "      {\n",
      "        \"88\": \"Repeated SSRIs Exposures Effects on Dopamine Receptors\"\n",
      "      },\n",
      "      {\n",
      "        \"89\": \"Hyperprolactinemia-related Symptoms\"\n",
      "      },\n",
      "      {\n",
      "        \"93\": \"SRRIs and Ocular Safety\"\n",
      "      },\n",
      "      {\n",
      "        \"97\": \"SSRI-Induced Mania\"\n",
      "      },\n",
      "      {\n",
      "        \"101\": \"Risk for Orofacial Pain Disorders\"\n",
      "      },\n",
      "      {\n",
      "        \"130\": \"Risk of Hallucinations\"\n",
      "      },\n",
      "      {\n",
      "        \"135\": \"Adulterants in Weight Loss Supplements\"\n",
      "      },\n",
      "      {\n",
      "        \"136\": \"Risk of Microscopic Colitis\"\n",
      "      },\n",
      "      {\n",
      "        \"142\": \"Risk of Priapism\"\n",
      "      },\n",
      "      {\n",
      "        \"145\": \"Risk of Reversible Cerebral Vasoconstriction Syndrome (RCVS)\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  \"Other\": {\n",
      "    \"Drugs\": {\n",
      "      \"Fluvoxamine\": [\n",
      "        {\n",
      "          \"9\": \"Fluvoxamine for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"39\": \"Fluvoxamine for Covid 19\"\n",
      "        },\n",
      "        {\n",
      "          \"59\": \"SSRIs (Fluvoxamine) for Schizophrenia\"\n",
      "        }\n",
      "      ],\n",
      "      \"Paroxetine\": [\n",
      "        {\n",
      "          \"10\": \"Paroxetine Bindeing\"\n",
      "        },\n",
      "        {\n",
      "          \"32\": \"Paroxetine\"\n",
      "        },\n",
      "        {\n",
      "          \"140\": \"Treatment of Paroxetine Induced Sexual Dysfunction\"\n",
      "        }\n",
      "      ],\n",
      "      \"Fluoxetine\": [\n",
      "        {\n",
      "          \"41\": \"Fluoxetine\"\n",
      "        }\n",
      "      ],\n",
      "      \"Escitalopram\": [\n",
      "        {\n",
      "          \"23\": \"Escitalopram for Depression\"\n",
      "        }\n",
      "      ],\n",
      "      \"Citalopram\": [\n",
      "        {\n",
      "          \"77\": \"Citalopram for Depression\"\n",
      "        }\n",
      "      ],\n",
      "      \"Sertraline\": [\n",
      "        {\n",
      "          \"54\": \"(Sertraline) Drug Delivery\"\n",
      "        },\n",
      "        {\n",
      "          \"61\": \"Sertraline for Depression\"\n",
      "        },\n",
      "        {\n",
      "          \"99\": \"Sertraline\"\n",
      "        }\n",
      "      ],\n",
      "      \"Agomelatine\": [\n",
      "        {\n",
      "          \"75\": \"Agomelatin for Depression\"\n",
      "        }\n",
      "      ],\n",
      "      \"Vilazodone\": [\n",
      "        {\n",
      "          \"113\": \"Vilazodone for Depression\"\n",
      "        }\n",
      "      ],\n",
      "      \"Psilocybin\": [\n",
      "        {\n",
      "          \"143\": \"Psilocybin for Depression\"\n",
      "        }\n",
      "      ],\n",
      "      \"Generic SSRIs\": [\n",
      "        {\n",
      "          \"111\": \"Generic SSRIs\"\n",
      "        }\n",
      "      ],\n",
      "      \"SSRIs\": [\n",
      "        {\n",
      "          \"115\": \"Selective serotonin reuptake inhibitors\"\n",
      "        }\n",
      "      ]\n",
      "    },\n",
      "    \"Ecotoxicology\": [\n",
      "      {\n",
      "        \"1\": \"Aquatic Ecotoxicology\"\n",
      "      },\n",
      "      {\n",
      "        \"83\": \"Wastewater Management\"\n",
      "      }\n",
      "    ],\n",
      "    \"Alternative Treatments\": [\n",
      "      {\n",
      "        \"35\": \"Herbal and Natural Compounds for Depression\"\n",
      "      },\n",
      "      {\n",
      "        \"106\": \"St. John's Wort for Depression\"\n",
      "      }\n",
      "    ],\n",
      "    \"Drug Utilization Patterns\": [\n",
      "      {\n",
      "        \"25\": \"SSRI Utilization Patterns\"\n",
      "      }\n",
      "    ],\n",
      "    \"Cost-Effectineness\": [\n",
      "      {\n",
      "        \"33\": \"Cost-Effectiveness\"\n",
      "      }\n",
      "    ],\n",
      "    \"OtherOther\": [\n",
      "      {\n",
      "        \"53\": \"Hot Flushes (Menopause)\"\n",
      "      },\n",
      "      {\n",
      "        \"84\": \"SSRI Use\"\n",
      "      },\n",
      "      {\n",
      "        \"98\": \"Gatways to Clinical Trials\"\n",
      "      },\n",
      "      {\n",
      "        \"100\": \"Canine Behavioral Disorders\"\n",
      "      },\n",
      "      {\n",
      "        \"135\": \"Adulterants in Weight Loss Supplements\"\n",
      "      },\n",
      "      {\n",
      "        \"146\": \"Gateways to Clinical Trials\"\n",
      "      },\n",
      "      {\n",
      "        \"147\": \"Depression in Infertile Women\"\n",
      "      },\n",
      "      {\n",
      "        \"148\": \"SSRIs for Olfactory reference syndrome (ORS)\"\n",
      "      }\n",
      "    ]\n",
      "  }\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "import json\n",
    "\n",
    "\n",
    "def transform_dict_to_legend(cluster_hierarchy_dict, cluster_label_dict):\n",
    "    \"\"\"\n",
    "    Transforms the cluster hierarchy dictionary by adding cluster labels to create a legend.\n",
    "    \"\"\"\n",
    "    # Ensure keys in cluster_label_dict are integers\n",
    "    cluster_label_dict = {int(k): v for k, v in cluster_label_dict.items()}\n",
    "\n",
    "    def transform(item):\n",
    "        if isinstance(item, dict):\n",
    "            return {k: transform(v) for k, v in item.items()}\n",
    "        elif isinstance(item, list):\n",
    "            return [transform(i) for i in item]\n",
    "        elif isinstance(item, int) and item in cluster_label_dict:\n",
    "            return {item: cluster_label_dict[item]}\n",
    "        else:\n",
    "            return item\n",
    "\n",
    "    return transform(cluster_hierarchy_dict)\n",
    "\n",
    "\n",
    "with open(CLUSTER_HIERARCHY_FOR_LEGEND_PATH, \"r\") as f:\n",
    "    cluster_hierarchy_dict = json.load(f)\n",
    "\n",
    "with open(CLUSTER_LABEL_DICT_PATH, \"r\") as f:\n",
    "    cluster_label_dict = json.load(f)\n",
    "\n",
    "# Transform the dictionary\n",
    "legend = transform_dict_to_legend(cluster_hierarchy_dict, cluster_label_dict)\n",
    "\n",
    "# Output the result\n",
    "print(json.dumps(legend, indent=2))\n",
    "\n",
    "# Optionally, save the result to a file\n",
    "# with open(\"path/to/output_legend.json\", \"w\") as f:\n",
    "#     json.dump(legend, f, indent=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save as JSON\n",
    "with open(OUTPUT_DIR + \"legend_full_label_tree_clusternr.json\", \"w\") as json_file:\n",
    "    json.dump(legend, json_file, indent=4)\n",
    "\n",
    "    # Save as JSON\n",
    "with open(\n",
    "    THREEJS_OUTPUT_DIR + \"legend_tree.json\",\n",
    "    \"w\",\n",
    ") as json_file:\n",
    "    json.dump(legend, json_file, indent=4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{0: 'Serotonin Receptor Studies',\n",
       " 2: 'Risks of Prenatal Exposure',\n",
       " 3: 'Quantification of SSRIs in Biological Samples',\n",
       " 5: 'SSRIs and the Cytochrome P450 System',\n",
       " 6: 'SSRI Neuroscience',\n",
       " 8: 'The Chronic Unpredictable Mild Stress Model of Depression',\n",
       " 10: 'Paroxetine Bindeing',\n",
       " 11: 'SSRIs Effect on Neural Processing of Emotional Cues',\n",
       " 14: 'SSRIs in Forced Swimming Test',\n",
       " 19: 'SSRIs Effect on Fear',\n",
       " 21: 'Serotonin Transporter Gene and Antidepressant Response',\n",
       " 22: 'SSRIs and Inflammation',\n",
       " 30: 'Serotonin Binding and Receptor Studies',\n",
       " 54: '(Sertraline) Drug Delivery',\n",
       " 60: 'SSRI Synthesis',\n",
       " 64: 'SSRIs Effects on Ion Channels',\n",
       " 65: 'Methylenedioxymethamphetamine (MDMA) Effects on Serotonin',\n",
       " 66: 'Genotype Mediated Response to SSRIs',\n",
       " 67: 'Pharmacological Perspectives on Antidepressants',\n",
       " 70: 'SSRIs Effects on Neuroendocrine System',\n",
       " 80: 'Pulmonary Hypertension',\n",
       " 81: 'Astrocyte Receptors',\n",
       " 88: 'Repeated SSRIs Exposures Effects on Dopamine Receptors',\n",
       " 90: 'Neurochemical and Electrophysiological Correlates of SSRIs',\n",
       " 92: 'Sex differences in SSRI Effects in Depression',\n",
       " 94: 'SSRIs for OCD-like behaviors',\n",
       " 102: 'SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients',\n",
       " 109: 'SSRIs Effect on Response Inhibition',\n",
       " 112: 'SSRIs in Model Organisms ( C. Elegans and Drosophilia)',\n",
       " 119: 'Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor for Cardiovascular Diseases',\n",
       " 120: 'Tryptophan Depletion in Depression',\n",
       " 121: 'Serotonin and Dopamine Release and Uptake Dynamics',\n",
       " 123: 'Olfactory Bulbectomized (OB) Rat Model for Depression',\n",
       " 126: 'Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression',\n",
       " 129: 'Novel Compounds Synthesis and Antidepressant Potential',\n",
       " 133: 'SSRIs and Galanin in Depression',\n",
       " 138: 'SSRIs Cellular Distribution',\n",
       " 140: 'Treatment of Paroxetine Induced Sexual Dysfunction',\n",
       " 4: 'SSRIs for Obsessive-Compulsive Disorder (OCD)',\n",
       " 7: 'Pediatric Depression',\n",
       " 13: 'SSRIs for PTSD',\n",
       " 17: 'Sequenced Depression Treatment',\n",
       " 18: 'Post-Stroke SSRI Use',\n",
       " 23: 'Escitalopram for Depression',\n",
       " 24: 'SSRIs for Pain',\n",
       " 26: 'SSRIs in Dementias',\n",
       " 27: 'SSRIs for Weight Management',\n",
       " 29: 'SSRIs and Cardiovascular Pathology',\n",
       " 31: 'SSRIs for Panic Disorder',\n",
       " 34: 'SSRIs for Dermatological Diseases',\n",
       " 36: 'SSRIs for Generalized Anxiety Disorder (GAD)',\n",
       " 38: 'SSRIs for Bipolar Depression',\n",
       " 43: 'Premature Ejaculation',\n",
       " 44: 'SSRIs for Depression in Parkinsons Patients',\n",
       " 46: 'SSRIs Effect on Sleep in Depressed Patients',\n",
       " 47: 'SSRIs for Depression in Diabetes Patients',\n",
       " 48: 'SSRIs for Irritable Bowel Syndrome',\n",
       " 49: 'SSRIs for Premenstrual Dysphoric Disorder (PMDD)',\n",
       " 50: 'SSRIs for Depression with Cognitive Impairment',\n",
       " 51: 'SSRIs for Eating Disorders',\n",
       " 52: 'SSRIs for Alcohol Dependence',\n",
       " 53: 'Hot Flushes (Menopause)',\n",
       " 55: 'SSRIs for Depression in in Epileptic Patients',\n",
       " 56: 'SSRIs for Autism Spectrum Disorders',\n",
       " 57: 'SSRIs for Substance Abuse (Cocaine)',\n",
       " 59: 'SSRIs (Fluvoxamine) for Schizophrenia',\n",
       " 61: 'Sertraline for Depression',\n",
       " 62: 'SSRIs for Social Anxiety Disorder',\n",
       " 69: 'SSRIs for Body Dysmorphic Disorder (BDD)',\n",
       " 71: 'SSRIs for Pediatric Anxiety',\n",
       " 73: 'SSRIs Effects on Antimicrobials and Gut Microbiome',\n",
       " 74: 'Depression Treatment Review',\n",
       " 75: 'Agomelatin for Depression',\n",
       " 76: 'Geriatric Depression',\n",
       " 77: 'Citalopram for Depression',\n",
       " 78: 'SSRIs for Personality Disorders and Related Traits',\n",
       " 85: 'Depression in Hepatitis Patients',\n",
       " 86: 'SSRIs and Augmentation for Treatment Resistant Depression',\n",
       " 87: 'SSRIs for Depression after Traumatic Brain Injury',\n",
       " 91: 'SSRIs for Fibromyalgia',\n",
       " 95: 'Transcranial Direct Current Stimulation (tDCS) for Depression',\n",
       " 96: 'SSRIs for Depression in Cancer',\n",
       " 103: 'SSRIs for Enuresis',\n",
       " 104: 'SSRIs for Migraine',\n",
       " 105: 'SSRIs for Postpartum Depression',\n",
       " 107: 'SSRIs for Depression in Kidney Disease Patients',\n",
       " 108: 'Behavioral Addictions',\n",
       " 110: 'SSRIs for Dysthymia',\n",
       " 113: 'Vilazodone for Depression',\n",
       " 114: 'SSRIs for Trichotillomania',\n",
       " 116: 'SSRIs for Depression in and Treatment of Multiple Sclerosis',\n",
       " 117: 'SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients',\n",
       " 118: 'Folate for Depression',\n",
       " 122: 'SSRIs for Congenital Myasthenic Syndrome (SCCMS)',\n",
       " 124: 'SSRIs for Depression in HIV-positive Patients',\n",
       " 125: 'SSRIs for Smoking Cessation',\n",
       " 127: 'SSRIs for Tinnitus ',\n",
       " 128: 'SSRIs for Syncope',\n",
       " 131: 'Exercise for Depression',\n",
       " 132: 'SSRIs for Narcolepsy',\n",
       " 134: \"SSRIs for Tourette's Syndrome\",\n",
       " 137: 'SSRIs for Pediatric OCD',\n",
       " 139: 'Psychotic Depression (STOP-PD Study)',\n",
       " 141: 'Childhood Abuse and Depression Treatment Response',\n",
       " 143: 'Psilocybin for Depression',\n",
       " 144: 'SSRIs for Depersonalization Disorder',\n",
       " 147: 'Depression in Infertile Women',\n",
       " 148: 'SSRIs for Olfactory reference syndrome (ORS)',\n",
       " 12: 'Risks of Prenatal Exposure (Rodents)',\n",
       " 15: 'Serotonin Syndrome',\n",
       " 16: 'Sexual Dysfunction',\n",
       " 20: 'Bleeding Risk',\n",
       " 28: 'Suicice Risk',\n",
       " 37: 'Fracture Risk',\n",
       " 40: 'QTC Prolongation',\n",
       " 42: 'Extrapyramidal Reactions Risk',\n",
       " 45: 'Oncopreventive and Oncolytic Properties of SSRIs',\n",
       " 58: 'Hepatotoxic Risk',\n",
       " 63: 'Drug Drug Interactions',\n",
       " 68: 'Hyponatremia Risk',\n",
       " 72: 'SSRI Safety Reviews',\n",
       " 79: 'Forensic Drug Concentration',\n",
       " 82: 'Withdrawal Symptoms',\n",
       " 89: 'Hyperprolactinemia-related Symptoms',\n",
       " 93: 'SRRIs and Ocular Safety',\n",
       " 97: 'SSRI-Induced Mania',\n",
       " 101: 'Risk for Orofacial Pain Disorders',\n",
       " 130: 'Risk of Hallucinations',\n",
       " 135: 'Adulterants in Weight Loss Supplements',\n",
       " 136: 'Risk of Microscopic Colitis',\n",
       " 142: 'Risk of Priapism',\n",
       " 145: 'Risk of Reversible Cerebral Vasoconstriction Syndrome (RCVS)',\n",
       " 1: 'Aquatic Ecotoxicology',\n",
       " 9: 'Fluvoxamine for Depression',\n",
       " 25: 'SSRI Utilization Patterns',\n",
       " 32: 'Paroxetine',\n",
       " 33: 'Cost-Effectiveness',\n",
       " 35: 'Herbal and Natural Compounds for Depression',\n",
       " 39: 'Fluvoxamine for Covid 19',\n",
       " 41: 'Fluoxetine',\n",
       " 83: 'Wastewater Management',\n",
       " 84: 'SSRI Use',\n",
       " 98: 'Gatways to Clinical Trials',\n",
       " 99: 'Sertraline',\n",
       " 100: 'Canine Behavioral Disorders',\n",
       " 106: \"St. John's Wort for Depression\",\n",
       " 111: 'Generic SSRIs',\n",
       " 115: 'Selective serotonin reuptake inhibitors',\n",
       " 146: 'Gateways to Clinical Trials'}"
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cluster_label_dict"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "condavenv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
